CDKN2A and melanoma: For example, overexpression of at least one cyclin D1-CDK4/6-INK4-Rb pathway component occurs in most cases of breast cancer (39), melanoma (40), head and neck squamous cell carcinoma (41), and liposarcoma (42, 43).